Hypertension On a population-wide basis, hypertension is the most common predisposing factor for AF. The relationship between AF and blood pressure (BP) was first convincingly demonstrated by the Framingham Heart Study (FHS), in which hypertensive patients (defined as a systolic BP [SBP] of 160 mm Hg or higher, diastolic BP [DBP] of 95 mm Hg or higher, or use of antihypertensive medications) were significantly more likely to develop AF (odds ratio, 1.5 for men and 1.4 for women) over a 38-year follow-up. Similarly, the Manitoba study demonstrated a 1.42-fold increased risk of AF in hypertensive individuals over a 44-year follow-up. 9 The association between higher SBP and AF has also been noted within a shorter follow-up time of 3 years.
Introduction Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia. 1 The lifetime risk of developing AF is almost 25% after the age of 40 years.
2,3 Approximately 2% of the United Kingdom population have AF, and it is estimated to increase to 4% by 2050.
4 Atrial fibrillation is associated with increased mortality and morbidity due to stroke, heart failure, and dementia. 1, [5] [6] [7] [8] Much focus has therefore been directed towards AF prevention, given the morbidity, mortality, and financial cost to health care systems associated with this arrhythmia.
There are a number of common conditions connected with the onset of AF, including hypertension, diabetes mellitus, smoking, alcohol consumption, increased body weight, exercise, and stress. This narrative review is divided into 2 parts. In Part 1, we discuss the relationship between AF and hypertension, diabetes, and smoking. In Part 2 (Kardiol Pol; May 2019 issue; in press), we will examine the evidence supporting the association between AF and alcohol consumption, increased body weight, exercise, and psychosocial factors. These weaknesses were addressed by the multicenter MESA study (Multi-Ethnic Study of Atherosclerosis), 16 which recruited an ethnically diverse cohort and measured BP on 3 separate occasions over a 5-year period to define a "sustained" BP category when 2 or more visits were within the same range. Both sustained prehypertension defined as a BP of 120 to 139 / 80 to 89 mm Hg and no antihypertensive medication use (hazard ratio [HR], 1.8; 95% CI, 1.004-3.2) and sustained hypertension defined as a BP of 140/90 mm Hg or higher or antihypertensive medication use at 2 consecutive visits (HR, 2.6; 95% CI, 1.6-4.4) were associated with an increased risk of AF. 16 However, one limitation of this study was that incident AF was identified through assessment of discharge summaries and inpatient Medicare data claim records, raising the possibility that patients with of less than 128 mm Hg. Similarly, baseline DBPof 80 mm Hg or higher was associated with a 1.79-fold (95% CI, 1.28-2.59) increased risk of AF onset, in comparison with a DBP of less than 80 mm Hg. 11 An analogous study in women (Women's Health Study), which recruited 39 876 female health professionals aged 45 years or older without any cardiovascular disease, cancer, or other major illnesses at baseline, also showed that higher SBP and DBP were associated with increasing incidence of AF (P for trend <0.0001 and 0.026, respectively).
12 Notably, both of the above studies had limited generalizability to non-Caucasians. Furthermore, the majority of data considered thus far are based on a single-visit BP check.
3,9,11-15 As BP is a continuous variable, it follows that a single BP measurement may not adequately identify hypertensive individuals. for AF, including body mass index, smoking, valvular disease, and diabetes. 14 Moreover, a visit-to-visit variability in SBP was also predictive of major adverse outcomes including ischemic stroke and major bleeding (P <0.001 for both). 17, 18 There are several explanations for the association between elevated BP and AF, including structural changes such as an increase in the left atrial diameter 19 and arterial stiffness. 14, 19 It is also plausible that enlargement of the left atrium secondary to hypertension may result in pulmonary vein trunk dilation, which subsequently plays a role in the genesis and maintenance of AF. 20 Elevated BP is also linked to conditions that predispose to AF development, such as advanced age, diabetes, and coronary heart disease.
The influence of antihypertensive medications on incident AF has been assessed in a variety of randomized controlled trials; however, the results have been mixed. Some trials clearly demonstrate a significant reduction in incident AF event rates, for example, with enalapril treatment in left ventricular dysfunction, 21 trandolapril treatment post myocardial infarction, 22 valsartan and candesartan in heart failure, 23, 24 and lisinopril with nitrates post myocardial infarction. 25 The LIFE trial 26 (Losartan Intervention for Endpoint) has additionally reported fewer AF events with losartan therapy compared with atenolol in hypertensive patients with electrocardiographic evidence of left ventricular hypertrophy. Furthermore, Verdecchia et al 27 have shown that the use of antihypertensive agents to achieve tight BP control with a target of less than 130 mm Hg is associated with a reduced incidence of AF compared with lenient BP control with a target of less than 140 mm Hg (HR, 0.46; 95% CI, 0.22-0.98; P = 0.044). In contrast, other trials have failed to show the change in AF event rates when ramipril was compared with placebo, 28 captopril with β-blocker and diuretics, 29 and conventional with newer antihypertensives.
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In summary, hypertension is associated with an increased risk (up to 2-fold) of incident AF, irrespective of sex or ethnicity. This relationship was consistent not only with SBP but also with pulse pressure. Moreover, this relationship is linear such that there is a 11% to 17% increased risk of AF with every 10-mm Hg rise in BP. The risk of incident AF falls with stricter BP control (up to 50% reduced risk), which similarly demonstrates this linear relationship. Therefore, adequate assessment of at-risk patients and tight BP control are recommended to reduce the risk of AF.
Diabetes mellitus and metabolic syndrome
Various epidemiological studies have investigated the relationship between diabetes mellitus and incident AF. The FHS was one of the earliest studies to recognize diabetes as an independent risk factor for AF, 13 while the Renfrew/Paisley study first associated elevated blood glucose revealed that smokers were more likely to develop AF, with an incidence rate of 9.0 and 5.0 per 1000 patient-years for smokers and nonsmokers, respectively. 41,42 There was additionally no difference in the risk of AF between men and women (P = 0.195). The Manitoba follow-up study similarly demonstrated an increased risk of AF in smokers (RR, 1.37; 95% CI, 1.00-1.87).
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Furthermore, the ARIC study 43 showed that both current (HR, 2.05; 95% CI, 1.71-2.47) and former smokers (HR, 1.32; 95% CI, 1.10-1.57) had an increased risk of AF, as compared with individuals who had never smoked. Those with the longest smoking history (>675 cigarette-years) had the highest risk of AF (RR, 2.10; 95% CI, 1.74-2.53) compared with nonsmokers. Those who quit smoking had a marginally lower risk of AF (HR, 0.88; 95% CI, 0.65-1.17), as compared with current smokers, although the difference was nonsignificant (P = 0.38). 43 The Rotterdam study similarly noted that current (RR, 1.51; 95% CI, 1.07-2.12) and former (RR, 1.49; 95% CI, 1.14-1.97) smokers had an increased risk of incident AF.
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What are the potential mechanisms? Smoking leads to an increased risk of AF by inducing oxidative stress, 45,46 inflammation, 45,46 and atrial fibrosis.
46,47 Further research to consider the threshold at which these pathophysiological changes are reversible to return AF risk to baseline are warranted.
In summary, smoking is not only a risk factor for AF but also for conditions that can predispose to heart failure and subsequent development of AF. Discontinuation of smoking may reduce the further risks of AF. More research is recommended to evaluate the impact of e-cigarettes and passive smoking on AF, as well as the impact of smoking cessation on reducing the risk of stroke, myocardial infarction, chronic kidney disease, and all-cause mortality.
Conclusion It is clear that hypertension, diabetes, and smoking predispose to the onset of AF, which is particularly important when considering that these risk factors are modifiable. Thus, strategies to promote BP and glycemic control as well as smoking cessation must shape public health strategy.
with a higher incidence of AF. 10, 31 A subgroup analysis of the VALUE Trial 32 (an international multicenter trial to assess the incidence of cardiac events in hypertensive patients taking valsartan or amlodipine) similarly showed that patients who developed diabetes during the follow-up of 4.2 years had a higher risk of incident AF (relative risk [RR], 1.38; 95% CI, 1.05-1.80) and were more likely to have persistent AF (HR, 1.66; 95% CI, 1.13-2.44).
A number of studies have sought to investigate the relationship between glycemic control and the incidence of AF. For instance, the ARIC Study 33 (Atherosclerosis Risk in Communities) showed a linear relationship between glycated hemoglobin A 1c (HbA 1c ) levels and AF incidence (HR, 1.13; 95% CI, 1.07-1.20 per 1% rise). The NAVIGA-TOR study 34 showed that for a 1.0-mmol rise in fasting glucose levels there was a 33% increase in the risk of AF (HR, 1.33; 95% CI, 1.11-1.59). A community-based case control study known as Group Health 35 further revealed that for each additional year of diabetes the risk of developing AF was 3% higher, suggesting that the longer duration of diabetes increases the risk of AF. Moreover, the Niigata Preventive Medicine Study 36 not only demonstrated that impaired fasting glucose was associated with a higher incidence of AF (HR, 1.35; 95% CI, 1.06-1.73; P = 0.01), but also showed that individuals with metabolic syndrome (defined by National Cholesterol Education Program Third Adult Treatment Panel criteria) had a higher risk of AF onset (HR, 1.88; P = 0.001).
A number of hypotheses have been postulated to explain the link between diabetes and AF, including diabetic microangiopathy, abnormal sympathetic tone, 37 diabetic cardiomyopathy, 38,39 and metabolic fluctuation. 37 It is also pertinent to consider whether adequate glycemic control may reduce the risk of AF. Unfortunately, data from 10 082 diabetic patients from the ACCORD trial 40 (Action to Control Cardiovascular Risk in Diabetes) showed that intensive glycemic control (HbA 1c <6.0%) compared with standard glycemic control (HbA 1c , 7.0%-7.9%) led to no significant difference in the incidence of AF (5.9 per 1000 patient-years and 6.37 per 1000 patient-years, respectively, P = 0.52).
In summary, diabetes increases the risk (11%-37%) of incident AF. This risk includes prediabetes, metabolic syndrome, and treated diabetes. The risk of AF increases with poor glycemic control and longer duration of diabetes. Intensive glycemic control does not offer significant advantages at least in the short term.
Smoking A number of studies have explored the relationship between smoking and development of AF, in particular, the influence of duration and quantity of tobacco on AF risk.
For instance, an analysis of 15 221 patients diagnosed with AF from the Shinken database
